Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene and Subunit Vaccines Based On Recombinant Human RSV Proteins: N-nanorings, P and M2-1, in Calves with Maternal Antibodies

The development of safe and effective vaccines against both bovine and human respiratory syncytial viruses (BRSV, HRSV) to be used in the presence of RSV-specific maternally-derived antibodies (MDA) remains a high priority in human and veterinary medicine. Herein, we present safety and efficacy resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Blodörn, Krister, Hägglund, Sara, Fix, Jenna, Dubuquoy, Catherine, Makabi-Panzu, Boby, Thom, Michelle, Karlsson, Per, Roque, Jean-Louis, Karlstam, Erika, Pringle, John, Eléouët, Jean-François, Riffault, Sabine, Taylor, Geraldine, Valarcher, Jean François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063758/
https://www.ncbi.nlm.nih.gov/pubmed/24945377
http://dx.doi.org/10.1371/journal.pone.0100392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063758/
https://www.ncbi.nlm.nih.gov/pubmed/24945377
http://dx.doi.org/10.1371/journal.pone.0100392

Ejemplares similares